The Mark Foundation for Cancer Research and the Samuel Waxman Cancer Research Foundation have awarded $1.5 million to six investigative teams focusing on the links between aging and cancer. The funding aims to improve prevention strategies and develop less toxic treatments.
Seven scientists received $250,000 per year for three years to pursue high-risk/high-reward projects addressing unmet needs in cancer research. The grants support innovative studies in basic, translational, and clinical cancer research.
The Mark Foundation has launched a new funding program for novel cancer therapeutics. Two projects have been selected, focusing on Ewing sarcoma and leukemias, targeting USP7 and CBP/p300 enzymes with highly selective inhibitors.
The Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University aims to develop innovative solutions for cancer immunotherapy. The center will utilize a combination of tools from astronomy image analysis, pathology, computer science, cancer genomics, and immunogenomics.
The Mark Foundation for Cancer Research has awarded six grants totaling $4.5 million to promising early career scientists pursuing projects in basic, translational, and clinical cancer research.
The Mark Foundation has awarded $2.2 million to fund projects exploring the intersection of AI and cancer research, including detecting pancreatic cancer tumors using 3D renderings and predicting patient responses to immunotherapies. Researchers aim to develop new tools for early cancer detection and improve treatment outcomes.
A new center will bring together researchers to better understand the relationships between advances in radiation therapy, cancer signaling pathways, and the immune system's ability to control cancer. The center aims to uncover novel insights into cancer biology with potential for more effective treatments.
The Mark Foundation has selected 14 new ASPIRE Award winners, funding high-risk, high-reward cancer research projects across the US and internationally. These projects focus on early cancer detection, immunotherapy, tumor microenvironment, and more, with the potential to advance cancer medicine.
The Mark Foundation has awarded grants to eight promising early career scientists pursuing innovative projects in cancer risk prediction, prevention, detection, and treatment. The recipients aim to tackle diverse areas of basic, translational, and early clinical cancer research.
A new UK-based institute at the University of Cambridge is using cutting-edge analytics to maximize the use of big data sets in cancer patient care. The Mark Foundation Institute for Integrated Cancer Medicine aims to integrate clinical, genomic, and image data to inform treatment decisions.